Cargando…
Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells
BACKGROUND: CD19-chimericantigen receptor (CAR) modified T cells (CD19-CAR T cells) have been well documented to possess potent anti-tumor properties against CD19-expressingleukemia cells. As a traditional medicine, metformin has been widely used to treat type II diabetes mellitus and more recently...
Autores principales: | Mu, Qian, Jiang, Miao, Zhang, Yuzhu, Wu, Fei, Li, Hui, Zhang, Wen, Wang, Fang, Liu, Jiang, Li, Liang, Wang, Dongshan, Wang, Wenjuan, Li, Shiwu, Song, Haibo, Tang, Dongqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892609/ https://www.ncbi.nlm.nih.gov/pubmed/29662316 http://dx.doi.org/10.2147/OTT.S154853 |
Ejemplares similares
-
Irisin Promotes Human Umbilical Vein Endothelial Cell Proliferation through the ERK Signaling Pathway and Partly Suppresses High Glucose-Induced Apoptosis
por: Song, Haibo, et al.
Publicado: (2014) -
Irisin Inhibits Atherosclerosis by Promoting Endothelial Proliferation Through microRNA126‐5p
por: Zhang, Yuzhu, et al.
Publicado: (2016) -
Assessment of chimeric antigen receptor T cytotoxicity by droplet microfluidics in vitro
por: Wong, Kuan Un, et al.
Publicado: (2022) -
Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway
por: Wu, Fei, et al.
Publicado: (2015) -
Protective Effect of Irisin on Atherosclerosis via Suppressing Oxidized Low Density Lipoprotein Induced Vascular Inflammation and Endothelial Dysfunction
por: Zhang, Yuzhu, et al.
Publicado: (2016)